Chronic stable angina pectoris: Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥70 bpm. Ivabradine is indicated: in adults unable to tolerate or with a contraindication to the use of beta-blockers; or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.
Chronic heart failure: Ivabradine is indicated for the treatment of stable chronic heart failure NYHA II to IV class with systolic dysfunction, in adult patients who are in sinus rhythm with heart rate ≥75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.
Other Services
Country
Account